Table 1. Primers used in the study a.
| Primer | Sequence (5′ to 3′)a |
| P1F | ATGGTACCAGGAAGTGAAGGCAT |
| P1R | ACGCTAGCAAGCTGGATGCAATA |
| P2F | AACCATGGCAAGGCCAAAGCTTTGAG |
| P2R | ACGGATCCAACAGAACTTGGAATATCATC |
| P3F | CAGTAAGAGAACACAAGCTAATTACT |
| P3R | GTCGCAAGTTTGCATTTATCATCT |
| P4F | AACAGGATCCTAGGTAATACCCGAGCTTC |
| P4R | AACCATGGTCTGACGCTCAGTGGAA |
| P5F | TCACGGTGTTATGGAAATAG |
| P5R | GACTGCGAGATCATAGATATAG |
| P6F | AAGGATCCTTGGAGGAAATTGATGGAA |
| P6R | CCTCTAGACCACTGACTTACAAGTAGAC |
| P7F | AAGGTACCAAGATAGAGAGAGAAAAGTG |
| P7R | TAGGATCCTTAAGGTTTTTTTGGACTTTCT |
| P8F | AAGGATCCTAAATTTAATAGAAGGAGGAA |
| P8R | AACTGCAGGTCTTGATTATCGGGCGAAGAG |
a
The underlined sequences are restriction enzyme sites: Acc65I sites (P1F and P7F), BamHI sites (P2R, P4F, P6F, P7R and P8F), NcoI sites (P2F and P4R), a NheI site (P1R), a PstI site (P8R), and an XbaI site (P6R).